Shares of Acceleron Pharma (XLRN) are on the rise on Monday after Bloomberg reported that the company is in advanced discussions to be acquired by a large pharmaceutical company for about $180 a share in cash. The potential buyer… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3377943/-Acceleron-up-amid-report-of-talks-Cowen-says–per-share-too-low-a-price)
previous post